Literature DB >> 6084040

3-hydroxy-3-methylglutaryl coenzyme A reductase in human liver microsomes: active and inactive forms and cross-reactivity with antibody against rat liver enzyme.

B Angelin, K Einarsson, L Liljeqvist, K Nilsell, R A Heller.   

Abstract

3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the enzyme catalyzing the rate-limiting step in cholesterol biosynthesis, exists in one active (dephosphorylated) and one inactive (phosphorylated) form in liver microsomes obtained from several animal species. The present study was undertaken in order to determine a) whether the human enzyme also exists in active and inactive readily interconvertible forms; b) whether the large inter-individual variation in HMG-CoA reductase activity observed in normal man can be explained by variations in the activation state of the enzyme; and c) to characterize the reactivity of antibodies raised against rat liver HMG-CoA reductase with the intact human microsomal enzyme. HMG-CoA reductase activity, assayed in microsomes prepared in the presence of 50 mM NaF, was only 17 +/- 3% of the activity observed in microsomes prepared from the same liver in the absence of fluoride. Preincubation of microsomes prepared in NaF with alkaline phosphatase resulted in a tenfold increase of enzyme activity, while the activity of microsomes prepared without fluoride was increased also (by about 45%) with this treatment. On the other hand, the activated enzyme could be inactivated by incubation of microsomes with Mg-ATP. In eleven normal weight, normolipidemic gallstone patients, the HMG-CoA reductase activity determined in microsomes prepared without NaF ("standard procedure") reflected well both the "expressed" activity (in microsomes prepared with NaF) and the "total" (fully activated) enzyme activity; correlation coefficients were +0.80 and +0.84, respectively. Preincubation of human liver microsomes with rabbit antiserum against partially purified HMG-CoA reductase from rat liver resulted in a 72 +/- 6% inhibition of enzyme activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6084040

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo.

Authors:  M J Rudling; E Reihnér; K Einarsson; S Ewerth; B Angelin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

2.  Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase.

Authors:  Massimiliano Cuccioloni; Matteo Mozzicafreddo; Michele Spina; Chi Nhan Tran; Maurizio Falconi; Anna Maria Eleuteri; Mauro Angeletti
Journal:  J Lipid Res       Date:  2011-02-25       Impact factor: 5.922

3.  Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat.

Authors:  M Rudling; P Parini; B Angelin
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

4.  Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism.

Authors:  K Einarsson; S Ericsson; S Ewerth; E Reihnér; M Rudling; D Ståhlberg; B Angelin
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 5.  Effects of bezafibrate on hepatic cholesterol metabolism.

Authors:  D Ståhlberg; E Reihnér; S Ewerth; K Einarsson; B Angelin
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Hepatic cholesterol and bile acid synthesis in Japanese patients with cholesterol gallstones.

Authors:  A Honda; T Yoshida; N Tanaka; Y Matsuzaki; B He; T Osuga; N Kobayashi; K Ozawa
Journal:  Gastroenterol Jpn       Date:  1993-06

7.  Age-related changes in the metabolism of cholesterol in rat liver microsomes.

Authors:  D Ståhlberg; B Angelin; K Einarsson
Journal:  Lipids       Date:  1991-05       Impact factor: 1.880

8.  Effects of pregnenolone-16 alpha-carbonitrile on the metabolism of cholesterol in rat liver microsomes.

Authors:  D Ståhlberg
Journal:  Lipids       Date:  1995-04       Impact factor: 1.880

9.  Stimulation of rat hepatic low density lipoprotein receptors by glucagon. Evidence of a novel regulatory mechanism in vivo.

Authors:  M Rudling; B Angelin
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Genetic variation and metabolic pathway intricacy govern the active compound content and quality of the Chinese medicinal plant Lonicera japonica thunb.

Authors:  Yuan Yuan; Lipu Song; Minhui Li; Guiming Liu; Yanan Chu; Luyu Ma; Yuanyuan Zhou; Xiao Wang; Wei Gao; Shuangshuang Qin; Jun Yu; Xumin Wang; Luqi Huang
Journal:  BMC Genomics       Date:  2012-05-20       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.